Table 3.
Variables contributing to the differences between the log serum intact FGF23 levels seen at the baseline and after 3 months’ sodium ferrous citrate supplementation
| Model 1 | ||
|---|---|---|
| Variables | F | P‐value |
| Differences in TSAT | 0.99 | 0.330 |
| Differences in serum phosphate | 0.09 | 0.771 |
| Differences in albumin‐adjusted serum Ca | 0.10 | 0.754 |
| Differences in log serum iPTH | 0.09 | 0.772 |
| Model 2 | ||
| Variables | F | P‐value |
| Differences in serum ferritin | 7.04 | 0.013 |
| Differences in serum phosphate | 2.62 | 0.118 |
| Differences in albumin‐adjusted serum Ca | 0.05 | 0.823 |
| Differences in log serum iPTH | 0.15 | 0.670 |
The analysis was performed using repeated measures, multivariate analysis of variance (MANOVA), and the results of the between‐subjects analyses are shown.
Differences: differences between the levels seen at the baseline and after 3 months’ sodium ferrous citrate supplementation
Ca, calcium; iPTH, intact parathyroid hormone; TSAT, transferrin saturation.